Aisling Capital is a leading investment firm specializing in healthcare, focusing on products, technologies, and global businesses that advance health. Since 2000, the firm has raised over $1.8 billion across four funds, investing in private and public companies across life sciences. Aisling Capital's team leverages clinical, operational, and financial expertise to identify and realize investments, actively working with portfolio companies to build successful enterprises.
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →